Skip to main content
. 2021 Jun 25;106(11):3265–3282. doi: 10.1210/clinem/dgab471

Figure 7.

Figure 7.

Tumors with gain vs no gain in the 10q11.21 cytoband were analyzed for differentially expressed genes in the same cytoband. RASSF4, TMEM72, and OR13A1 were all significantly upregulated in the tumor cohort when analyzing RNA sequencing data, suggesting that the augmented expression of one or several of these genes might be associated with recurrent 10q11.21 gains observed in the cohort.